Lazard Asset Management LLC Morphic Holding, Inc. Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$26.01 - $48.69 $55,323 - $103,563
-2,127 Reduced 87.1%
315 $11,000
Q3 2022

Nov 14, 2022
BUY
$22.23 - $33.37 $54,285 - $81,489
2,442 New
2,442 $69,000
Q1 2021

May 14, 2021
SELL
$29.77 - $84.85 $58,765 - $167,493
-1,974 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$25.66 - $34.55 $50,652 - $68,201
1,974 New
1,974 $66,000

Others Institutions Holding MORF

# of Institutions
8
Shares Held
4.7M
Call Options Held
0
Put Options Held
0
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email